ENTRY       D10770                      Drug
NAME        Albutrepenonacog alfa (INN);
            Albutrepenonacog alfa (genetical recombination) (JAN);
            Idelvion (TN)
SEQUENCE    YNSGKLEEFV QGNLERECME EKCSFEEARE VFENTERTTE FWKQYVDGDQ CESNPCLNGG
            SCKDDINSYE CWCPFGFEGK NCELDVTCNI KNGRCEQFCK NSADNKVVCS CTEGYRLAEN
            QKSCEPAVPF PCGRVSVSQT SKLTRAETVF PDVDYVNSTE AETILDNITQ STQSFNDFTR
            VVGGEDAKPG QFPWQVVLNG KVDAFCGGSI VNEKWIVTAA HCVETGVKIT VVAGEHNIEE
            TEHTEQKRNV IRIIPHHNYN AAINKYNHDI ALLELDEPLV LNSYVTPICI ADKEYTNIFL
            KFGSGYVSGW GRVFHKGRSA LVLQYLRVPL VDRATCLRST KFTIYNNMFC AGFHEGGRDS
            CQGDSGGPHV TEVEGTSFLT GIISWGEECA MKGKYGIYTK VSRYVNWIKE KTKLTPVSQT
            SKLTRAETVF PDVDAHKSEV AHRFKDLGEE NFKALVLIAF AQYLQQCPFE DHVKLVNEVT
            EFAKTCVADE SAENCDKSLH TLFGDKLCTV ATLRETYGEM ADCCAKQEPE RNECFLQHKD
            DNPNLPRLVR PEVDVMCTAF HDNEETFLKK YLYEIARRHP YFYAPELLFF AKRYKAAFTE
            CCQAADKAAC LLPKLDELRD EGKASSAKQR LKCASLQKFG ERAFKAWAVA RLSQRFPKAE
            FAEVSKLVTD LTKVHTECCH GDLLECADDR ADLAKYICEN QDSISSKLKE CCEKPLLEKS
            HCIAEVENDE MPADLPSLAA DFVESKDVCK NYAEAKDVFL GMFLYEYARR HPDYSVVLLL
            RLAKTYETTL EKCCAAADPH ECYAKVFDEF KPLVEEPQNL IKQNCELFEQ LGEYKFQNAL
            LVRYTKKVPQ VSTPTLVEVS RNLGKVGSKC CKHPEAKRMP CAEDYLSVVL NQLCVLHEKT
            PVSDRVTKCC TESLVNRRPC FSALEVDETY VPKEFNAETF TFHADICTLS EKERQIKKQT
            ALVELVKHKP KATKEQLKAV MDDFAAFVEK CCKADDKETC FAEEGKKLVA ASQAALGL
            (Disulfide bridge: 18-23, 51-62, 56-71, 73-82, 88-99, 95-109, 111-124, 132-289, 206-222, 336-350, 361-389, 486-495, 508-524, 523-534, 557-602, 601-610, 633-679, 698-712, 711-722, 749-794, 793-802, 825-871, 870-881, 894-910, 909-920, 947-992, 991-1000)
  TYPE      Peptide
CLASS       Blood modifier agent
             DG02016  Hemostatics
              DG02014  Blood coagulation accelerant
               DG02013  Blood coagulation factor
REMARK      Therapeutic category: 6349
            ATC code: B02BD04
            Chemical structure group: DG00171
            Product (DG00171): D08797<JP/US> D08794<JP> D05201<JP> D10757<JP> D10770<JP>
EFFICACY    Bleeding suppressant, Replenisher (coagulation factor)
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BD Blood coagulation factors
                 B02BD04 Coagulation factor IX
                  D10770  Albutrepenonacog alfa (INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               634  Human blood preparations
                6349  Others
                 D10770  Albutrepenonacog alfa (INN); Albutrepenonacog alfa (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG02016  Hemostatics
               DG02014  Blood coagulation accelerant
                DG02013  Blood coagulation factor
                 DG00171  Blood coagulation factor IX
                  D10770  Albutrepenonacog alfa
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10770
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10770
            Drug groups [BR:br08330]
             Blood modifier agent
              DG02016  Hemostatics
               DG02014  Blood coagulation accelerant
                DG02013  Blood coagulation factor
                 DG00171  Blood coagulation factor IX
DBLINKS     CAS: 1357448-54-4
            PubChem: 310920488
///
